Correlation Between Utah Medical and Akoya Biosciences
Can any of the company-specific risk be diversified away by investing in both Utah Medical and Akoya Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Utah Medical and Akoya Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Utah Medical Products and Akoya Biosciences, you can compare the effects of market volatilities on Utah Medical and Akoya Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Utah Medical with a short position of Akoya Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Utah Medical and Akoya Biosciences.
Diversification Opportunities for Utah Medical and Akoya Biosciences
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Utah and Akoya is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Utah Medical Products and Akoya Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akoya Biosciences and Utah Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Utah Medical Products are associated (or correlated) with Akoya Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akoya Biosciences has no effect on the direction of Utah Medical i.e., Utah Medical and Akoya Biosciences go up and down completely randomly.
Pair Corralation between Utah Medical and Akoya Biosciences
Given the investment horizon of 90 days Utah Medical Products is expected to generate 0.26 times more return on investment than Akoya Biosciences. However, Utah Medical Products is 3.89 times less risky than Akoya Biosciences. It trades about -0.07 of its potential returns per unit of risk. Akoya Biosciences is currently generating about -0.03 per unit of risk. If you would invest 8,365 in Utah Medical Products on September 8, 2024 and sell it today you would lose (1,981) from holding Utah Medical Products or give up 23.68% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Utah Medical Products vs. Akoya Biosciences
Performance |
Timeline |
Utah Medical Products |
Akoya Biosciences |
Utah Medical and Akoya Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Utah Medical and Akoya Biosciences
The main advantage of trading using opposite Utah Medical and Akoya Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Utah Medical position performs unexpectedly, Akoya Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akoya Biosciences will offset losses from the drop in Akoya Biosciences' long position.Utah Medical vs. Precision Optics, | Utah Medical vs. Repro Med Systems | Utah Medical vs. InfuSystems Holdings | Utah Medical vs. Milestone Scientific |
Akoya Biosciences vs. Bone Biologics Corp | Akoya Biosciences vs. Nuwellis | Akoya Biosciences vs. Heart Test Laboratories | Akoya Biosciences vs. Tivic Health Systems |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |